Collaborative science is the foundation upon which GNF is built. At the institute, researchers work within interdisciplinary teams as well as with colleagues at Novartis to pursue innovative basic, translational, and drug discovery research.
GNF has established scientific collaborations with many external researchers at various academic institutions. In addition, GNF collaborates with a number of non-profit foundations, including the Wellcome Trust and the Medicines for Malaria Venture and has recently announced a partnership with the Juvenile Diabetes Research Foundation. GNF also participates in federally-funded research efforts such as the Protein Structure Initiative as a member of the Joint Center for Structural Genomics.
As a result of its basic and translational research efforts, GNF is continually creating new technologies, many of which have commercial applications. For example, GNF Systems was started to commercially manufacture high throughput instrumentation developed by GNF's Engineering group. Further information on GNF Systems can be found here. GNF welcomes additional licensing and commercialization inquires, as these opportunities provide a valuable source of funding to support our research programs. Please send such inquires to BD@gnf.org.